📰 Alacyclovir News
Page 6 - Alacyclovir News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alacyclovir. Real-time updates on events, politics, business and more.
December 23, 2022
Mercks COVID antiviral molnupiravir speeds up recovery but does not reduce the hospitalization or death rate in higher-risk vaccinated adults, detailed data from a large study showed.
December 14, 2022
Drugmaker Pfizer said on Tuesday it is working to improve supply of its COVID-19 antiviral drug Paxlovid in China in order to ensure adequate access to the drug as cases rise in the country.
December 14, 2022
The US government agreed to pay Pfizer nearly $2 billion for an additional 3.7 million courses of its COVID-19 antiviral treatment Paxlovid, the company said on Tuesday.
December 12, 2022
With the last monoclonal antibody treatment de-authorized, experts are focused on existing and new antivirals, new monoclonals, and convalescent plasma (again).
December 7, 2022
Pfizer and Clear Creek Bio on Tuesday announced a collaboration to identify a potential drug candidate and develop a new class of oral treatment against COVID-19, as Pfizer seeks to expand its anti-infective pipeline.
December 5, 2022
The number of medications available to treat COVID-19 continues to get smaller as the coronavirus changes to outsmart treatments.
December 1, 2022
Titled "6-Month Consequences of COVID-19 in Patients Discharged From Hospital: A Cohort Study," the paper has been cited nearly 1600 times, according to Clarivates Web of Science.
November 30, 2022
The CDC says more than 300 people die each day from COVID-19. But its still two to three times more than the death rate from the flu, "renewing debate about what is an acceptable loss. "
November 28, 2022
In the past 2 years there was relatively little flu activity, but this time the US is experiencing an early and potentially harsh flu season.